BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12956298)

  • 1. Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field.
    Dispas M; Schynts F; Lemaire M; Letellier C; Vanopdenbosch E; Thiry E; Kerkhofs P
    Vet Rec; 2003 Aug; 153(7):209-12. PubMed ID: 12956298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
    Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
    Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle.
    Muylkens B; Meurens F; Schynts F; Farnir F; Pourchet A; Bardiau M; Gogev S; Thiry J; Cuisenaire A; Vanderplasschen A; Thiry E
    J Gen Virol; 2006 Aug; 87(Pt 8):2149-2154. PubMed ID: 16847110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Eradication of BHV-1 in cattle herds in Saxony-Anhalts using a vaccine lacking a marker--report of an experience].
    Gehrmann B; Tyrpe A; Körber R
    Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):203-7. PubMed ID: 12784553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and pathogenic studies on a glycoprotein E variant field isolate of bovine herpesvirus 1.
    Egyed L; Ros C; Belák S
    Vet Res Commun; 2000 Sep; 24(6):423-31. PubMed ID: 11014611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
    Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
    Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
    Muylkens B; Meurens F; Schynts F; de Fays K; Pourchet A; Thiry J; Vanderplasschen A; Antoine N; Thiry E
    Vet Microbiol; 2006 Mar; 113(3-4):283-91. PubMed ID: 16321480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus.
    Toussaint JF; Rziha HJ; Bauer B; Letellier C; Kerkhofs P
    Vet Rec; 2004 Oct; 155(18):553-8. PubMed ID: 15559987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
    Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
    Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.
    Strube W; Auer S; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
    Vet Microbiol; 1996 Nov; 53(1-2):181-9. PubMed ID: 9011010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
    Schynts F; Lemaire M; Ros C; Belak S; Thiry E
    Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of bovine herpesvirus type 1 in blood from naturally infected cattle by using a sensitive PCR that discriminates between wild-type virus and virus lacking glycoprotein E.
    Fuchs M; Hübert P; Detterer J; Rziha HJ
    J Clin Microbiol; 1999 Aug; 37(8):2498-507. PubMed ID: 10405392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
    Makoschey B; Beer M
    Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments.
    Mars MH; de Jong MC; van Oirschot JT
    Vaccine; 2000 Apr; 18(19):1975-81. PubMed ID: 10706958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on latency in calves by five vaccines against bovine herpesvirus-1 infection.
    Castrucci G; Frigeri F; Salvatori D; Ferrari M; Dico ML; Rotola A; Sardonini Q; Petrini S; Cassai E
    Comp Immunol Microbiol Infect Dis; 2002 Jul; 25(4):205-15. PubMed ID: 12135235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period.
    van Engelenburg FA; Kaashoek MJ; van Oirschot JT; Rijsewijk FA
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2387-92. PubMed ID: 7561782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to glycoprotein E after bovine herpesvirus type 1 infection in passively immunised, glycoprotein E-negative calves.
    Lemaire M; Schynts F; Meyer G; Thiry E
    Vet Rec; 1999 Feb; 144(7):172-6. PubMed ID: 10097325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No vaccine interference between bovine coronavirus and bovine herpesvirus-1 in a randomized trial when coadministrating two intranasal modified-live viral vaccines to neonatal calves.
    Bolton MW; Nordstrom S; Hill K; Midla L; Rajamanikam K; Griebel PJ
    Am J Vet Res; 2024 May; 85(5):. PubMed ID: 38457927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.